Six subphenotypes in septic shock: Latent class analysis of the PROWESS Shock study

[1]  Peter Nürnberg,et al.  Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[2]  R. Luckmann,et al.  Does Infection Site Matter? A Systematic Review of Infection Site Mortality in Sepsis , 2017, Journal of intensive care medicine.

[3]  G. Van den Berghe,et al.  Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failure , 2016, Journal of Intensive Care.

[4]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[5]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[6]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[7]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[8]  Simon C. Brewer,et al.  Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome , 2015, Intensive Care Medicine.

[9]  Anand Kumar,et al.  Association between source of infection and hospital mortality in patients who have septic shock. , 2014, American journal of respiratory and critical care medicine.

[10]  Andrew Rhodes,et al.  Drotrecogin alfa (activated) in adults with septic shock. , 2012, The New England journal of medicine.

[11]  P. Barie,et al.  Statistical analysis plan of PROWESS SHOCK study , 2010, Intensive Care Medicine.

[12]  Craig K. Enders,et al.  Applied Missing Data Analysis. Methodology in the Social Sciences Series. , 2010 .

[13]  P. Barie,et al.  Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock , 2008, Intensive Care Medicine.

[14]  B. Muthén,et al.  Deciding on the Number of Classes in Latent Class Analysis and Growth Mixture Modeling: A Monte Carlo Simulation Study , 2007 .

[15]  J. Kellum,et al.  Comment on “Changes in acid-base balance following bolus infusion of 20% albumin solution in humans” by Bruegger et al. , 2006, Intensive Care Medicine.

[16]  K. Bollen,et al.  Improper Solutions in Structural Equation Models , 2001 .

[17]  Bengt Muthén,et al.  Second-generation structural equation modeling with a combination of categorical and continuous latent variables: New opportunities for latent class–latent growth modeling. , 2001 .